CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

43.88 USD
+0.58 (+1.34%)
At close:
43.88 USD
0 (0%)
After Hours:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • CXT had positive earnings in the past year.
  • CXT had a positive operating cash flow in the past year.
  • CXT had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CXT had a positive operating cash flow.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 4.66%, CXT is doing good in the industry, outperforming 70.16% of the companies in the same industry.
  • CXT has a Return On Equity of 11.58%. This is in the better half of the industry: CXT outperforms 75.00% of its industry peers.
  • CXT has a Return On Invested Capital of 7.93%. This is in the better half of the industry: CXT outperforms 75.81% of its industry peers.
  • CXT had an Average Return On Invested Capital over the past 3 years of 11.93%. This is above the industry average of 8.11%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With a decent Profit Margin value of 8.76%, CXT is doing good in the industry, outperforming 79.84% of the companies in the same industry.
  • CXT's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CXT (15.91%) is better than 90.32% of its industry peers.
  • CXT's Operating Margin has improved in the last couple of years.
  • CXT has a Gross Margin of 42.48%. This is in the better half of the industry: CXT outperforms 72.58% of its industry peers.
  • In the last couple of years the Gross Margin of CXT has grown nicely.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. CXT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
  • CXT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CXT has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 1.90. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CXT has a Altman-Z score of 1.90. This is in the lower half of the industry: CXT underperforms 64.52% of its industry peers.
  • CXT has a debt to FCF ratio of 5.75. This is a neutral value as CXT would need 5.75 years to pay back of all of its debts.
  • The Debt to FCF ratio of CXT (5.75) is comparable to the rest of the industry.
  • CXT has a Debt/Equity ratio of 0.91. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.91, CXT is not doing good in the industry: 85.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.9
ROIC/WACC0.84
WACC9.48%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • CXT has a Current Ratio of 1.50. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • CXT's Current ratio of 1.50 is on the low side compared to the rest of the industry. CXT is outperformed by 76.61% of its industry peers.
  • A Quick Ratio of 1.20 indicates that CXT should not have too much problems paying its short term obligations.
  • CXT's Quick ratio of 1.20 is on the low side compared to the rest of the industry. CXT is outperformed by 66.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • The Earnings Per Share has been growing slightly by 1.12% on average over the past years.
  • Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 11.43% in the last year.
  • The Revenue has been decreasing by -9.71% on average over the past years.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.31% on average over the next years.
  • CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.29% yearly.
EPS Next Y6.26%
EPS Next 2Y8.36%
EPS Next 3Y6.31%
EPS Next 5YN/A
Revenue Next Year6.31%
Revenue Next 2Y5.29%
Revenue Next 3Y4.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.81, the valuation of CXT can be described as reasonable.
  • 93.55% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.86, CXT is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.17, the valuation of CXT can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, CXT is valued cheaper than 92.74% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (37.39), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 10.81
Fwd PE 10.17
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaply inside the industry as 90.32% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CXT is valued cheaply inside the industry as 91.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.71
EV/EBITDA 8.89
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CXT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.73
PEG (5Y)9.65
EPS Next 2Y8.36%
EPS Next 3Y6.31%

5

5. CXT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.66%, CXT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.45, CXT pays a better dividend. On top of this CXT pays more dividend than 92.74% of the companies listed in the same industry.
  • CXT's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.66%

5.2 History

  • The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
  • CXT has decreased its dividend recently.
Dividend Growth(5Y)6.42%
Div Incr Years1
Div Non Decr Years1
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 26.88% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • The dividend of CXT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP26.88%
EPS Next 2Y8.36%
EPS Next 3Y6.31%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (4/10/2026, 8:15:29 PM)

After market: 43.88 0 (0%)

43.88

+0.58 (+1.34%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-06
Inst Owners113.84%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner Change5.59%
Market Cap2.52B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target91.36 (108.2%)
Short Float %12.25%
Short Ratio7.87
Dividend
Industry RankSector Rank
Dividend Yield 1.66%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.37%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.26%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 10.81
Fwd PE 10.17
P/S 1.52
P/FCF 12.71
P/OCF 10.44
P/B 2.01
P/tB N/A
EV/EBITDA 8.89
EPS(TTM)4.06
EY9.25%
EPS(NY)4.31
Fwd EY9.83%
FCF(TTM)3.45
FCFY7.87%
OCF(TTM)4.2
OCFY9.58%
SpS28.84
BVpS21.81
TBVpS-8.15
PEG (NY)1.73
PEG (5Y)9.65
Graham Number44.64
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.9
F-Score4
WACC9.48%
ROIC/WACC0.84
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.26%
EPS Next 2Y8.36%
EPS Next 3Y6.31%
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.31%
Revenue Next 2Y5.29%
Revenue Next 3Y4.29%
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.82%
EBIT Next 3Y9.51%
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


How profitable is CRANE NXT CO (CXT) stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


What is the financial health of CRANE NXT CO (CXT) stock?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


What is the earnings growth outlook for CRANE NXT CO?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to grow by 6.26% in the next year.